Novel Insights on Use of Doxorubicin to Treat Chemoresistant TNBC by Immunotherapy

Authors

Tze-Chen Hsieh, New York Medical CollegeFollow
Joseph M. Wu, New York Medical CollegeFollow

DOI

10.17352/2455-8591.000024

Journal Title

International Journal of Immunotherapy and Cancer Research

First Page

16

Last Page

18

Document Type

Article

Publication Date

7-2020

Department

Biochemistry and Molecular Biology

Recommended Citation

Hsieh, T., & Wu, J. M. (2020). Novel Insights on Use of Doxorubicin to Treat Chemoresistant TNBC by Immunotherapy. International Journal of Immunotherapy and Cancer Research, 6 (1), 16-18. https://doi.org/10.17352/2455-8591.000024